| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8446811 | European Journal of Cancer | 2012 | 6 Pages |
Abstract
This phase II study suggests that sunitinib monotherapy demonstrated marginal efficacy in metastatic BTC patients although toxicity should be concerned in Asian population.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Jun Ho Yi, Sumitra Thongprasert, Jeeyun Lee, D.C. Doval, Se Hoon Park, Joon Oh Park, Young Suk Park, Won Ki Kang, Ho Yeong Lim,